期刊文献+

β受体阻滞剂对起搏器置入心衰患者左室功能的影响

The Effect of β-Blockers on Ventricular Function in Patients with Heart Failure
原文传递
导出
摘要 目的:观察β受体阻滞剂在治疗心衰患者时对心室收缩功能的影响。方法:将安装起博器有心衰症状的左室收缩功能障碍的66例患者,起博频率调整为60次每分并随即分为两组,治疗组33例在接受ACEI或ARB,氨体舒通治疗稳定的基础上加用β受体阻滞剂治疗;对照组33例接受ACEI或ARB,氨体舒通治疗;疗程为9个月,治疗前后行心脏彩色多谱勒检查,测量左室射血分数。结果:治疗组与对照组比较,治疗组显著提高平均左室射血分数。结论:在不改变心率的条件下,β受体阻滞剂在治疗心衰患者时可维持心室收缩功能。 Objective:To evaluated the effect on ventricular function in patients with heart failure treated with β-blockers.Methods:Sixty-six patients in pacemaker-dependent patients with symptomatic left ventricular(LV)systolic dysfunction seted pacing rate at 60 ppm.Thirty-three patients treated by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers,β-blockers,and spironolactone.Other 33 patients treated by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers,and spironolac...
出处 《华西医学》 CAS 2008年第6期1409-1410,共2页 West China Medical Journal
关键词 心力衰竭 Β受体阻滞剂 治疗 heart failure β-blocker therapy
  • 相关文献

参考文献10

  • 1[1]Bristow MR.Beta-adrenergic receptor blockade in chronic heart failure[J].Circulation,2000,101(5):558-569.
  • 2[2]Doughty RN,Whalley GA,Gamble G,et al.On behalf of the Australia and New-Zealand heart failure research collaborative group:left ventricular remodelling with carvedilol in patients with congestive heart failure due to ischaemic heart disease[J].JACC,1997,29:1060-1066.
  • 3[3]Dubach P,Myers J,Bonetti P,et al.Effects of bisoprolol fumarate on left ventricular size,function,and exercise capacity in patients with heart failure:analysis with magnetic resonance myocardial tagging[J].Am Heart J,2002,143:676-683.
  • 4[4]Bristow MR,Ginsburg R,Minobe W,et al.Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts[J].N Engl J Med,1982,307:205-211.
  • 5[5]Lowes BD,Gilbert EM,Abraham WT,et al.Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents[J].N Engl J Med,2002,346:1357-1365.
  • 6[6]Poole-Wilson PA,Swedberg K,Cleland JG,et al.Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET):randomised controlled trial[J].Lancet,2003,362:7-13.
  • 7[7]Nagatsu M,Spinale FG,Koide M,et al.Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction[J].Circulation,2000,101:653-659.
  • 8[8]Cice G,Tagliamonte E,Ferrara L,et al.Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy:double-blind,randomized,placebo-controlled study[J].Eur Heart J,2000,21:1259-1264.
  • 9[9]Cleland JG,Pennell DJ,Ray SG,et al.Carvedilol hibernating reversible ischaemia trial:marker of success investigators.Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial):randomised controlled trial[J].Lancet,2003,362:14-21.
  • 10[10]Jourdain P,Funck F,Fulla Y,et al.Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol[J].Eur J Heart Fail,2002,4:269-276.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部